OpenURL Connection Search

Select item for more details and to access through your institution.

Progress in imaging by α‐synuclein Positron Emission Tomography.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.073427
By:
- Bennacef, Idriss;
- Zeng, Zhizhen;
- Miller, Patricia J;
- Riffel, Kerry;
- Purcell, Mona L;
- Haley, Hyking D;
- Meng, Xiangjun;
- Yuchuan, Wang;
- Roecker, Anthony J;
- Shaw, Anthony W;
- Stump, Craig A;
- Mitchell, Helen J;
- Tong, Ling V;
- Fawaz, Maria V;
- Drolet, Robert E;
- Ma, Lei M;
- Marcus, Jacob;
- Li, Wenping;
- Hostetler, Eric D.
Publication type:
Article
Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man.
Published in:
Scientific Reports, 2016, p. 27147, doi. 10.1038/srep27147
By:
- Gotter, Anthony L.;
- Forman, Mark S.;
- Harrell, Charles M.;
- Stevens, Joanne;
- Svetnik, Vladimir;
- Yee, Ka Lai;
- Li, Xiaodong;
- Roecker, Anthony J.;
- Fox, Steven V.;
- Tannenbaum, Pamela L.;
- Garson, Susan L.;
- Lepeleire, Inge De;
- Calder, Nicole;
- Rosen, Laura;
- Struyk, Arie;
- Coleman, Paul J.;
- Herring, W. Joseph;
- Renger, John J.;
- Winrow, Christopher J.
Publication type:
Article
The dual orexin receptor antagonist, DORA-22, lowers histamine levels in the lateral hypothalamus and prefrontal cortex without lowering hippocampal acetylcholine.
Published in:
Journal of Neurochemistry, 2017, v. 142, n. 2, p. 204, doi. 10.1111/jnc.14055
By:
- Yao, Lihang;
- Ramirez, Andres D.;
- Roecker, Anthony J.;
- Fox, Steven V.;
- Uslaner, Jason M.;
- Smith, Sean M.;
- Hodgson, Robert;
- Coleman, Paul J.;
- Renger, John J.;
- Winrow, Christopher J.;
- Gotter, Anthony L.
Publication type:
Article
Discovery of 5′′-Chloro- N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2′:5′,3′′-terpyridine-3′-carboxamide (MK-1064): A Selective Orexin 2 Receptor Antagonist (2-SORA) for the Treatment of Insomnia.
Published in:
ChemMedChem, 2014, v. 9, n. 2, p. 311, doi. 10.1002/cmdc.201300447
By:
- Roecker, Anthony J.;
- Mercer, Swati P.;
- Schreier, John D.;
- Cox, Christopher D.;
- Fraley, Mark E.;
- Steen, Justin T.;
- Lemaire, Wei;
- Bruno, Joseph G.;
- Harrell, C. Meacham;
- Garson, Susan L.;
- Gotter, Anthony L.;
- Fox, Steven V.;
- Stevens, Joanne;
- Tannenbaum, Pamela L.;
- Prueksaritanont, Thomayant;
- Cabalu, Tamara D.;
- Cui, Donghui;
- Stellabott, Joyce;
- Hartman, George D.;
- Young, Steven D.
Publication type:
Article
Cover Picture: Discovery of 5′′-Chloro- N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2′:5′,3′′-terpyridine-3′-carboxamide (MK-1064): A Selective Orexin 2 Receptor Antagonist (2-SORA) for the Treatment of Insomnia (ChemMedChem 2/2014)
Published in:
ChemMedChem, 2014, v. 9, n. 2, p. 241, doi. 10.1002/cmdc.201490000
By:
- Roecker, Anthony J.;
- Mercer, Swati P.;
- Schreier, John D.;
- Cox, Christopher D.;
- Fraley, Mark E.;
- Steen, Justin T.;
- Lemaire, Wei;
- Bruno, Joseph G.;
- Harrell, C. Meacham;
- Garson, Susan L.;
- Gotter, Anthony L.;
- Fox, Steven V.;
- Stevens, Joanne;
- Tannenbaum, Pamela L.;
- Prueksaritanont, Thomayant;
- Cabalu, Tamara D.;
- Cui, Donghui;
- Stellabott, Joyce;
- Hartman, George D.;
- Young, Steven D.
Publication type:
Article

Found: 5

Progress in imaging by α‐synuclein Positron Emission Tomography.

Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man.

The dual orexin receptor antagonist, DORA-22, lowers histamine levels in the lateral hypothalamus and prefrontal cortex without lowering hippocampal acetylcholine.

Discovery of 5′′-Chloro- N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2′:5′,3′′-terpyridine-3′-carboxamide (MK-1064): A Selective Orexin 2 Receptor Antagonist (2-SORA) for the Treatment of Insomnia.

Cover Picture: Discovery of 5′′-Chloro- N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2′:5′,3′′-terpyridine-3′-carboxamide (MK-1064): A Selective Orexin 2 Receptor Antagonist (2-SORA) for the Treatment of Insomnia (ChemMedChem 2/2014)